vs
Side-by-side financial comparison of AVIENT CORP (AVNT) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $760.6M, roughly 2.0× AVIENT CORP). AVIENT CORP runs the higher net margin — 2.2% vs -13.6%, a 15.8% gap on every dollar of revenue. On growth, AVIENT CORP posted the faster year-over-year revenue change (1.9% vs -5.3%). AVIENT CORP produced more free cash flow last quarter ($125.4M vs $96.0M). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -4.2%).
Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
AVNT vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $760.6M | $1.5B |
| Net Profit | $16.9M | $-205.0M |
| Gross Margin | 30.2% | 49.2% |
| Operating Margin | 5.2% | -9.8% |
| Net Margin | 2.2% | -13.6% |
| Revenue YoY | 1.9% | -5.3% |
| Net Profit YoY | -65.0% | -288.1% |
| EPS (diluted) | $0.18 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $760.6M | $1.5B | ||
| Q3 25 | $806.5M | $1.6B | ||
| Q2 25 | $866.5M | $1.6B | ||
| Q1 25 | $826.6M | $1.5B | ||
| Q4 24 | $746.5M | $1.6B | ||
| Q3 24 | $815.2M | $1.6B | ||
| Q2 24 | $849.7M | $1.6B | ||
| Q1 24 | $829.0M | $1.6B |
| Q4 25 | $16.9M | $-205.0M | ||
| Q3 25 | $32.6M | $160.0M | ||
| Q2 25 | $52.6M | $145.0M | ||
| Q1 25 | $-20.2M | $87.0M | ||
| Q4 24 | $48.3M | $109.0M | ||
| Q3 24 | $38.2M | $359.0M | ||
| Q2 24 | $33.6M | $195.0M | ||
| Q1 24 | $49.4M | $201.0M |
| Q4 25 | 30.2% | 49.2% | ||
| Q3 25 | 30.4% | 53.5% | ||
| Q2 25 | 32.1% | 54.8% | ||
| Q1 25 | 31.8% | 55.6% | ||
| Q4 24 | 34.8% | 56.3% | ||
| Q3 24 | 32.1% | 58.3% | ||
| Q2 24 | 30.3% | 58.4% | ||
| Q1 24 | 33.6% | 59.0% |
| Q4 25 | 5.2% | -9.8% | ||
| Q3 25 | 8.3% | 15.2% | ||
| Q2 25 | 11.1% | 14.4% | ||
| Q1 25 | 0.1% | 6.7% | ||
| Q4 24 | 11.5% | 8.1% | ||
| Q3 24 | 9.5% | 13.1% | ||
| Q2 24 | 8.5% | 14.6% | ||
| Q1 24 | 11.3% | 14.5% |
| Q4 25 | 2.2% | -13.6% | ||
| Q3 25 | 4.0% | 10.0% | ||
| Q2 25 | 6.1% | 9.1% | ||
| Q1 25 | -2.4% | 5.8% | ||
| Q4 24 | 6.5% | 6.8% | ||
| Q3 24 | 4.7% | 22.7% | ||
| Q2 24 | 4.0% | 12.1% | ||
| Q1 24 | 6.0% | 12.4% |
| Q4 25 | $0.18 | $-0.78 | ||
| Q3 25 | $0.36 | $0.61 | ||
| Q2 25 | $0.57 | $0.56 | ||
| Q1 25 | $-0.22 | $0.33 | ||
| Q4 24 | $0.53 | $0.42 | ||
| Q3 24 | $0.41 | $1.38 | ||
| Q2 24 | $0.36 | $0.75 | ||
| Q1 24 | $0.54 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $574.0M |
| Total DebtLower is stronger | $1.9B | $8.6B |
| Stockholders' EquityBook value | $2.4B | $752.0M |
| Total Assets | $6.0B | $12.9B |
| Debt / EquityLower = less leverage | 0.81× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $574.0M | ||
| Q3 25 | — | $672.0M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | — | $547.0M | ||
| Q4 24 | — | $675.0M | ||
| Q3 24 | — | $763.0M | ||
| Q2 24 | — | $704.0M | ||
| Q1 24 | — | $575.0M |
| Q4 25 | $1.9B | $8.6B | ||
| Q3 25 | $2.0B | $8.8B | ||
| Q2 25 | $2.0B | $8.9B | ||
| Q1 25 | $2.1B | $9.0B | ||
| Q4 24 | $2.1B | $8.9B | ||
| Q3 24 | $2.1B | $8.7B | ||
| Q2 24 | $2.1B | $8.7B | ||
| Q1 24 | $2.1B | $8.7B |
| Q4 25 | $2.4B | $752.0M | ||
| Q3 25 | $2.4B | $906.0M | ||
| Q2 25 | $2.4B | $733.0M | ||
| Q1 25 | $2.3B | $542.0M | ||
| Q4 24 | $2.3B | $472.0M | ||
| Q3 24 | $2.4B | $493.0M | ||
| Q2 24 | $2.3B | $144.0M | ||
| Q1 24 | $2.3B | $48.0M |
| Q4 25 | $6.0B | $12.9B | ||
| Q3 25 | $6.1B | $13.6B | ||
| Q2 25 | $6.1B | $13.5B | ||
| Q1 25 | $5.8B | $13.2B | ||
| Q4 24 | $5.8B | $13.1B | ||
| Q3 24 | $6.0B | $12.8B | ||
| Q2 24 | $5.9B | $12.2B | ||
| Q1 24 | $5.9B | $11.9B |
| Q4 25 | 0.81× | 11.49× | ||
| Q3 25 | 0.83× | 9.74× | ||
| Q2 25 | 0.86× | 12.14× | ||
| Q1 25 | 0.90× | 16.52× | ||
| Q4 24 | 0.89× | 18.81× | ||
| Q3 24 | 0.88× | 17.75× | ||
| Q2 24 | 0.90× | 60.11× | ||
| Q1 24 | 0.90× | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $167.8M | $141.0M |
| Free Cash FlowOCF − Capex | $125.4M | $96.0M |
| FCF MarginFCF / Revenue | 16.5% | 6.4% |
| Capex IntensityCapex / Revenue | 5.6% | 3.0% |
| Cash ConversionOCF / Net Profit | 9.93× | — |
| TTM Free Cash FlowTrailing 4 quarters | $195.0M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.8M | $141.0M | ||
| Q3 25 | $72.1M | $264.0M | ||
| Q2 25 | $112.8M | $220.0M | ||
| Q1 25 | $-51.1M | $75.0M | ||
| Q4 24 | $122.6M | $390.0M | ||
| Q3 24 | $71.1M | $141.0M | ||
| Q2 24 | $105.9M | $332.0M | ||
| Q1 24 | $-42.8M | $76.0M |
| Q4 25 | $125.4M | $96.0M | ||
| Q3 25 | $47.4M | $218.0M | ||
| Q2 25 | $85.8M | $181.0M | ||
| Q1 25 | $-63.6M | $43.0M | ||
| Q4 24 | $81.5M | $335.0M | ||
| Q3 24 | $46.1M | $99.0M | ||
| Q2 24 | $74.5M | $300.0M | ||
| Q1 24 | $-67.2M | $30.0M |
| Q4 25 | 16.5% | 6.4% | ||
| Q3 25 | 5.9% | 13.6% | ||
| Q2 25 | 9.9% | 11.4% | ||
| Q1 25 | -7.7% | 2.8% | ||
| Q4 24 | 10.9% | 21.0% | ||
| Q3 24 | 5.7% | 6.3% | ||
| Q2 24 | 8.8% | 18.7% | ||
| Q1 24 | -8.1% | 1.8% |
| Q4 25 | 5.6% | 3.0% | ||
| Q3 25 | 3.1% | 2.9% | ||
| Q2 25 | 3.1% | 2.4% | ||
| Q1 25 | 1.5% | 2.1% | ||
| Q4 24 | 5.5% | 3.5% | ||
| Q3 24 | 3.1% | 2.7% | ||
| Q2 24 | 3.7% | 2.0% | ||
| Q1 24 | 2.9% | 2.8% |
| Q4 25 | 9.93× | — | ||
| Q3 25 | 2.21× | 1.65× | ||
| Q2 25 | 2.14× | 1.52× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | 2.54× | 3.58× | ||
| Q3 24 | 1.86× | 0.39× | ||
| Q2 24 | 3.15× | 1.70× | ||
| Q1 24 | -0.87× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNT
| Color Additives And Inks | $466.0M | 61% |
| Specialty Engineered Materials | $295.5M | 39% |
OGN
Segment breakdown not available.
